Thrombin receptor PAR4 drives canonical NLRP3 inflammasome signaling in the heart
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Thrombin receptor PAR4 drives canonical NLRP3 inflammasome signaling in the heart
Authors
Keywords
-
Journal
BASIC RESEARCH IN CARDIOLOGY
Volume 115, Issue 2, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-01-08
DOI
10.1007/s00395-019-0771-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cardiac fibroblast activation and hyaluronan synthesis in response to hyperglycemia and diet-induced insulin resistance
- (2019) Daniel J. Gorski et al. Scientific Reports
- Vaspin prevents myocardial injury in rats model of diabetic cardiomyopathy by enhancing autophagy and inhibiting inflammation
- (2019) Xuelian Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cell-Specific Roles of NLRP3 Inflammasome in Myocardial Infarction
- (2019) Masafumi Takahashi JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Coriolus versicolor alleviates diabetic cardiomyopathy by inhibiting cardiac fibrosis and NLRP3 inflammasome activation
- (2019) Yueqiu Wang et al. PHYTOTHERAPY RESEARCH
- Rivaroxaban Suppresses the Progression of Ischemic Cardiomyopathy in a Murine Model of Diet-Induced Myocardial Infarction
- (2019) Jingyi Liu et al. Journal of Atherosclerosis and Thrombosis
- PAR4 (Protease-Activated Receptor 4)
- (2018) Xu Han et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation
- (2018) Chunxia Yao et al. CIRCULATION
- NLRP3 regulates platelet integrin αIIbβ3 outside-in signaling, hemostasis and arterial thrombosis
- (2018) Jianlin Qiao et al. HAEMATOLOGICA
- Evidence for functional PAR-4 thrombin receptor expression in cardiac fibroblasts and its regulation by high glucose
- (2018) Sonja Kleeschulte et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Thrombin induces protease-activated receptor 1 signaling and activation of human atrial fibroblasts and dabigatran prevents these effects
- (2018) Paola Altieri et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Attenuation of type-1 diabetes-induced cardiovascular dysfunctions by direct thrombin inhibitor in rats: a mechanistic study
- (2018) Yogesh Bulani et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Cardiovascular diseases, NLRP3 inflammasome, and western dietary patterns
- (2018) Luis E. Pavillard et al. PHARMACOLOGICAL RESEARCH
- Inhibition of advanced glycation endproduct (AGE) rescues against streptozotocin-induced diabetic cardiomyopathy: Role of autophagy and ER stress
- (2018) Zhaohui Pei et al. TOXICOLOGY LETTERS
- NLRP3 regulates platelet integrin αIIbβ3 outside-in signaling, hemostasis and arterial thrombosis
- (2018) Jianlin Qiao et al. HAEMATOLOGICA
- Oxidative Stress and NLRP3-Inflammasome Activity as Significant Drivers of Diabetic Cardiovascular Complications: Therapeutic Implications
- (2018) Arpeeta Sharma et al. Frontiers in Physiology
- Cardiomyocyte Inflammasome Signaling in Cardiomyopathies and Atrial Fibrillation: Mechanisms and Potential Therapeutic Implications
- (2018) Gong Chen et al. Frontiers in Physiology
- Platelet activity and hypercoagulation in type 2 diabetes
- (2018) Lesha Pretorius et al. Cardiovascular Diabetology
- Role of inflammatory signaling in atrial fibrillation
- (2018) Larry Scott et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Reactive oxygen species signalling in the diabetic heart: emerging prospect for therapeutic targeting
- (2017) Adam J Wilson et al. HEART
- Tissue factor levels in type 2 diabetes mellitus
- (2017) Prashilla Soma et al. INFLAMMATION RESEARCH
- Thrombin promotes diet-induced obesity through fibrin-driven inflammation
- (2017) Anna K. Kopec et al. JOURNAL OF CLINICAL INVESTIGATION
- Cardiac oxidative stress in diabetes: Mechanisms and therapeutic potential
- (2017) Alyssa Faria et al. PHARMACOLOGY & THERAPEUTICS
- Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleeding
- (2017) Pancras C. Wong et al. Science Translational Medicine
- Protease-Activated Receptor PAR-4: An Inducible Switch between Thrombosis and Vascular Inflammation?
- (2017) Bernhard Rauch et al. THROMBOSIS AND HAEMOSTASIS
- Implication of Free Fatty Acids in Thrombin Generation and Fibrinolysis in Vascular Inflammation in Zucker Rats and Evolution with Aging
- (2017) Jérémy Lagrange et al. Frontiers in Physiology
- PAR4 (Protease-Activated Receptor 4) Antagonism With BMS-986120 Inhibits Human Ex Vivo Thrombus Formation
- (2017) Simon J. Wilson et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Diabetes mellitus: The linkage between oxidative stress, inflammation, hypercoagulability and vascular complications
- (2016) Caroline Pereira Domingueti et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Humanizing the Protease-Activated Receptor (PAR) Expression Profile in Mouse Platelets by Knocking PAR1 into the Par3 Locus Reveals PAR1 Expression Is Not Tolerated in Mouse Platelets
- (2016) Shauna L. French et al. PLoS One
- Endoplasmic reticulum stress and protein quality control in diabetic cardiomyopathy
- (2015) Lifang Yang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Actions of thrombin in the interstitium
- (2015) G. G. de Ridder et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Association of weight gain with coronary artery disease, inflammation and thrombogenicity
- (2015) Rahul Chaudhary et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Thrombin Receptor Protease-Activated Receptor 4 Is a Key Regulator of Exaggerated Intimal Thickening in Diabetes Mellitus
- (2014) Goran Pavic et al. CIRCULATION
- Blockade of proteinase-activated receptor 4 inhibits neutrophil recruitment in experimental inflammation in mice
- (2014) Lindisley F. Gomides et al. INFLAMMATION RESEARCH
- Sphingosine-1-phosphate induces thrombin receptor PAR-4 expression to enhance cell migration and COX-2 formation in human monocytes
- (2014) Shailaja Mahajan-Thakur et al. JOURNAL OF LEUKOCYTE BIOLOGY
- NLRP3 Gene Silencing Ameliorates Diabetic Cardiomyopathy in a Type 2 Diabetes Rat Model
- (2014) Beibei Luo et al. PLoS One
- Hypercoagulability in overweight and obese subjects who are asymptomatic for thrombotic events
- (2014) E. Campello et al. THROMBOSIS AND HAEMOSTASIS
- Rosuvastatin Alleviates Diabetic Cardiomyopathy by Inhibiting NLRP3 Inflammasome and MAPK Pathways in a Type 2 Diabetes Rat Model
- (2013) Beibei Luo et al. CARDIOVASCULAR DRUGS AND THERAPY
- Protease-Activated Receptor 1 Inhibition by SCH79797 Attenuates Left Ventricular Remodeling and Profibrotic Activities of Cardiac Fibroblasts
- (2013) Dmitry L. Sonin et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- An Immunohistochemical Analysis of Tissue Thrombin Expression in the Human Atria
- (2013) Keiichi Ito et al. PLoS One
- Defining the cellular repertoire of GPCRs identifies a profibrotic role for the most highly expressed receptor, protease-activated receptor 1, in cardiac fibroblasts
- (2012) Aaron N. Snead et al. FASEB JOURNAL
- Inflammatory and Prothrombotic States in Obese Children of European Descent
- (2012) Sophie Stoppa-Vaucher et al. Obesity
- Trunk weighted obesity, cholesterol levels and low grade inflammation are main determinants for enhanced thrombin generation
- (2011) Florian Prüller et al. ATHEROSCLEROSIS
- Metabolic, inflammatory, endothelial and haemostatic markers in a group of Italian obese children and adolescents
- (2011) Paola Giordano et al. EUROPEAN JOURNAL OF PEDIATRICS
- Differential Expression of NLRP3 among Hematopoietic Cells
- (2011) G. Guarda et al. JOURNAL OF IMMUNOLOGY
- Impaired glucose metabolism and type 2 diabetes are associated with hypercoagulability: potential role of central adiposity and low-grade inflammation – The Hoorn Study
- (2011) Hanneke J.B.H. Beijers et al. THROMBOSIS RESEARCH
- High Glucose Enhances Thrombin Responses via Protease-Activated Receptor-4 in Human Vascular Smooth Muscle Cells
- (2010) Seema Dangwal et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Could rusalatide acetate be the future drug of choice for diabetic foot ulcers and fracture repair?
- (2008) Darrell H Carney et al. EXPERT OPINION ON PHARMACOTHERAPY
- TP508 (Chrysalin®) Reverses Endothelial Dysfunction and Increases Perfusion and Myocardial Function in Hearts With Chronic Ischemia
- (2008) Theresa W. Fossum et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started